BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-08-05 14:45
Net Asset Value(s)
English 4.0 KB
2020-08-04 10:07
Net Asset Value(s)
English 4.0 KB
2020-08-03 15:47
Net Asset Value(s)
English 4.0 KB
2020-07-31 12:51
Net Asset Value(s)
English 4.0 KB
2020-07-30 15:11
Net Asset Value(s)
English 4.0 KB
2020-07-29 13:30
Net Asset Value(s)
English 4.0 KB
2020-07-28 09:26
Net Asset Value(s)
English 4.0 KB
2020-07-27 12:00
Net Asset Value(s)
English 4.0 KB
2020-07-24 08:13
Net Asset Value(s)
English 4.1 KB
2020-07-23 08:12
Net Asset Value(s)
English 4.1 KB
2020-07-22 09:55
Net Asset Value(s)
English 4.0 KB
2020-07-21 08:23
Net Asset Value(s)
English 4.1 KB
2020-07-20 08:16
Net Asset Value(s)
English 4.1 KB
2020-07-17 08:54
Net Asset Value(s)
English 4.0 KB
2020-07-16 09:10
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Stayble Therapeutics AB Logo
Develops treatments for chronic pain originating from spinal disc conditions.
Sweden
STABL
STCUBE Logo
Develops immuno-oncology therapies targeting novel immune checkpoints for cancer.
South Korea
052020
StemRIM Inc. Logo
Develops regenerative medicine that uses the body's own stem cells for tissue repair.
Japan
4599
Surrozen, Inc./DE Logo
Develops drug candidates to selectively modulate the Wnt pathway for tissue repair.
United States of America
SRZN
SyntekaBio,Inc. Logo
An AI-driven drug discovery company using supercomputing to accelerate development.
South Korea
226330
Tango Therapeutics, Inc. Logo
A clinical-stage biotech developing precision oncology medicines via synthetic lethality.
United States of America
TNGX
Taysha Gene Therapies, Inc. Logo
Clinical-stage company developing AAV-based gene therapies for severe CNS diseases.
United States of America
TSHA
Tectonic Therapeutic, Inc. Logo
Clinical-stage biotech developing biologics targeting G-Protein Coupled Receptors (GPCRs).
United States of America
TECX
Telomir Pharmaceuticals, Inc. Logo
Pre-clinical pharma company developing a small molecule for aging and chronic disease.
United States of America
TELO
Tempest Therapeutics, Inc. Logo
Clinical-stage oncology company developing small molecule and cell therapies for cancer.
United States of America
TPST

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.